10 April 2014
PuriCore plc Notice of 2013 Preliminary ResultsPuriCore plc (LSE: PURI), a global company focused on safe and effective protection against the spread of infectious pathogens , will announce its preliminary results for the year ended 31 December 2013 on Thursday, 24 April 2014. PuriCore will also host a conference call for analysts and investors at 1:00 pm BST (8:00 am EDT). To participate, please use the conference call details below:
Conference Call Details
From the UK: +44 20 3139 4830
From the US: +1 718 873 9077
Pin code: 11633567#
A recording will be archived on the Company's website atinvestor.puricore.com/events.
Enquiries
UK | US |
FTI Consulting | Sage Strategic Marketing |
Mo Noonan/Simon Conway | Jennifer Guinan |
Victoria Foster Mitchell | +1 610 410 8111 |
+44 (0) 20 7831 3113 | Jennifer@sagestrat.com |
About PuriCore
PuriCore plc(LSE: PURI) is a global company focused on safe and effective protection against the spread of infectious pathogens without causing harm to human or animal health or to the environment. PuriCore's antimicrobial technology and complementary products are used in well-established core businesses and emerging sectors of two broad markets: Health Sciences and Food & Agriculture. In the Health Sciences market, PuriCore is the leading full provider of all products and services required for a safe, efficient, and compliant endoscope decontamination to protect patients and staff in UK hospitals. PuriCore's breakthrough wound care technology is used to treat chronic and acute wounds including diabetic ulcers and burns in humans, for atopic dermatitis as private-labelled dermatologic treatments for humans, and to manage wounds in all species of companion and farm animals in the animal health segment. In the Food & Agriculture market, PuriCore's portfolio is used by three of the top-five US supermarket retailers to provide savings in labour costs and improvements in inventory loss and to address cross contamination of pathogens on fresh produce and floral products. In addition, the Company is progressing its research and development programmes on the use of its technology as an agricultural fungicide. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK. To receive additional information on PuriCore, visitwww.puricore.com.
This information is provided by RNS
distributed by |